Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Gastric Cancer proteome analysis for untreated and treated patients

ABSTRACT: Gastric Cancer proteome analysis for untreated and treated (PTX+RAM) patients

ORGANISM(S): Homo Sapiens (human)

SUBMITTER: Jun Adachi

PROVIDER: PXD050311 | JPOST Repository | Wed Sep 18 00:00:00 BST 2024

REPOSITORIES: jPOST

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	200207_NC_tTMT01_IMAC_f1.raw	Raw
	200207_NC_tTMT01_IMAC_f2.raw	Raw
	200207_NC_tTMT01_IMAC_f3.raw	Raw
	200207_NC_tTMT01_IMAC_f4.raw	Raw
	200207_NC_tTMT01_IMAC_f5.raw	Raw

Items per page:

1 - 5 of 20

Similar Datasets

Gastric cancer samples of Mexican patients

Project description:Gastric cancer samples of Mexican patients

| PRJNA481039 | ENA

Gastric cancer ascites proteome

Project description:Gastric cancer is one of the most lethal malignancies with high mortality and gastric cancer-specific biomarker is need due to the lack of specific method for early screening, diagnosis, and prognosis of the patients with gastric cancer. Ascites is known for an important source for conducing biomarker discovery because it contains the secreted proteins from malignant cells, growth factors, and cytokines. In this study, we have conducted a comprehensive proteome study using ascites of patients with inflammatory diseases and gastric cancer. In the discovery stage, we have identified 2761 ascites-specific proteins, where 234 proteins were quantitated using the label free quantitation method, the normalized spectral abundance factor (NSAF); 152 and 82 proteins showed up and down-regulated pattern, respectively. Our ascites proteome can be used as baseline data for the discovery of novel biomarkers of the gastric cancer.

2018-04-16 | PXD002213 | Pride

Clinical response of metastatic gastric cancer patients to cisplatin and fluorouracil (CF) combination chemotherapy

Project description:This study was conducted to identify transcriptional profiles predictive of a clinical response of metastatic gastric cancer patients to cisplatin and fluorouracil (CF) combination chemotherapy. Endoscopic biopsy samples were collected from CF-treated metastatic gastric cancer patients prior to therapy and following the development of resistance to therapy.

2011-06-01 | E-GEOD-14208 | biostudies-arrayexpress

Gene expression outcome for gastric cancer patients

Project description:The gene expression of the three cancer patients who had operation were compared with the genes of the three normal cases. Three gastric cancer patients were compared with the three normal persons.

2014-10-01 | E-GEOD-49051 | biostudies-arrayexpress

MicroRNA profiling of human AGS gastric cancer cell line was treated with the selective COX-2 inhibitor celecoxib

Project description:AGS gastric cancer cell line was treated with the selective COX-2 inhibitor celecoxib. microRNA expression profile was analyzed between untreated cells and cells treated with celecoxib.

2009-07-11 | E-MEXP-2231 | biostudies-arrayexpress

Comprehensive transcriptome profile of AGS gastric cancer cells treated with flavonoid prunetin

Project description:Gastric cancer is the common type of malignancy positioned at second in mortality rate causing burden worldwide with increasing treatment options. The application of transcriptomics technologies possesses the high efficiency of identifying key metabolic pathways and functional genes in cancer research.Prunetin (PRU) is an O-methylated flavonoid that belongs to the group of isoflavone executing beneficial activities. In the current study, a transcriptome profile on treated and untreated conditions of flavonoid prunetin was performed in order identify the differential expression of genes which eventually aids in preditcing candidate biomarkers.

2022-03-21 | GSE198930 | GEO

Expression profiles of microRNAs in gastric cancer

Project description:We analyzed expression profiles of microRNAs from 22 paired gastric cancer and normal tissues and identified differentially expressed microRNAs. RNA from paired normal and tumor specimens in 22 gastric cancer patients were extracted and treated for microRNA microarray analysis.

2011-04-21 | E-GEOD-28700 | biostudies-arrayexpress

Comparative genomic hybridization of non-tumor stomach tissue from gastric cancer patients

Project description:Non-tumor stomach tissue from gastric cancer patients.

2007-03-27 | E-SMDB-3964 | biostudies-arrayexpress

microRNA expression profiles in bone marrow fractions from gastric cancer patients

Project description:Both disseminated tumor cells and noncancerous host cells contributed to cancer progression cooperatively in bone marrow. Bone marrow samples were obtained from 4 gastric cancer patients, and were separated into 3 fractions (CD45 positive, CD45 negative/EpCAM positive, and CD14 positive fractions) by the automagnetic-activated cell separation (AutoMACS) system using CD45, EpCAM, and CD14 microbeads (Miltenyi Biotec, Germany). microRNA expression profiles in each fractions were evaluated in order to identify candidate prognostic markers for gastric cancer patients.

2013-08-23 | GSE40325 | GEO

Peritoneal Carcinomatosis of gastric cancer

Project description:Peritoneal carcinomatosis is a frequent finding in patients with primary gastric cancer, and it is associated with a poor prognosis. A major mechanism in peritoneal carcinomatosis is the dissemination of cancer cells into the abdominal cavity, mainly in diffuse gastric adenocarcinoma. The features that enable diffuse primary gastric tumours to develop peritoneal dissemination have been little investigated and are only incompletely understood. We therefore compared the gene expression profile in patients with diffuse primary gastric cancer with and without peritoneal carcinomatosis. Specimens from consecutive gastric cancer patients with and without peritoneal carcinomatosis were investigated using oligonucleotide microarrays. Keywords: Disease state analysis

2008-01-31 | GSE8657 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data